An active used for the look of even tone and clarity.
More on this ingredient: read the guide.
Generally layer fine together; sequence thinnest to thickest.
Generally compatible; some alternate to manage overall load.
Generally layer well together.
Both are used for post-inflammatory marks and both are gentler than the classic brighteners. Commonly layered; azelaic acid also calms the redness side, which tranexamic acid does not address.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
A neutral reference and a lawful-lane shop. Information for those who seek it — never promotion.
This site provides neutral scientific reference and sells only products lawful in your region. Nothing here is medical advice, a recommendation, or an offer to supply unapproved medicines. No dosing or administration is published for research compounds. Cosmetic peptides per Regulation (EC) 1223/2009. Unapproved injectable peptides are neither sold nor advertised in the EU (Directive 2001/83/EC, Title VIII). © 2026 Vallydia.